ABBOTT FILES NDA FOR PROSTATE CANCER DRUG
606350
Abbott Laboratories filed a New Drug Application with the Food and Drug Administration for its drug Xinlay (atrasentan) to be used as a treatment for metastatic hormone-refractory prostate cancer.
558549
The FDA releases its documents on Adolor's lead drug.
154457
German drug maker Bayer AG said on Monday  that its drug Nexavar had been approved in Japan for the  treatment of kidney cancer.
711508
MADISON, NJ - Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration (news - web sites) granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
251744
Johnson & Johnson JNJ.N has sued   Boston Scientific Corp.BSX.N and Abbott Laboratories Inc.   ABT.N, seeking at least $5.5 billion in damages related to   J&J's failed bid for medical device maker Guidant Corp.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
454204
British scientists have discovered a new  way to improve the effectiveness of drugs used to treat  prostate cancer.
115547
AstraZeneca Plc's experimental cancer  drug AZD2281 has been given orphan drug status by the European  Medicines Agency for treating women with ovarian cancer,  Britain's second biggest drugmaker said on Tuesday.
208946
The Food and Drug Administration agreed Friday to allow a drug currently used against advanced breast cancer to be prescribed to prevent the disease from recurring in women who have been treated for early forms of the disease.
422908
- Bayer HealthCare, a U.S.-based unit of Bayer AG , stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet the main goal of improved overall survival.
499261
Abbott Laboratories Inc. on Friday said it submitted its application to the U.S. Food and Drug Administration for its drug-coated stent called Xience and expects to start selling the heart device in the first half of 2008.
529837
Neurochem hints at the data for its Alzheimer's disease drug candidate.
524945
The US Food and Drug Administration has granted fast-trackapproval to Tarceva (erlotinib) to treat advanced non-small cell lungcancer that has failed to respond to other therapy.
519863
The company faces a pivotal clinical trial.
702862
British scientists have discovered a new way to improve the effectiveness of drugs used to treat prostate cancer.
118432
The US Food and Drug Administration (FDA) has approved the Eli Lilly drug Alimta, for the treatment of advanced non-small cell lung cancer in previously treated patients.